Guanylate-binding protein-1 is a potential new therapeutic target for triple-negative breast cancer

BACKGROUND: Triple-negative breast cancer (TNBC) is characterized by a lack of estrogen and progesterone receptor expression (ESR and PGR, respectively) and an absence of human epithelial growth factor receptor (ERBB2) amplification. Approximately 15–20% of breast malignancies are TNBC. Patients wit...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Cancer
Main Authors: Quintero, Melissa, Adamoski, Douglas, Reis, Larissa Menezes dos, Ascenção, Carolline Fernanda Rodrigues, Oliveira, Krishina Ratna Sousa de, Gonçalves, Kaliandra de Almeida, Dias, Marília Meira, Carazzolle, Marcelo Falsarella, Dias, Sandra Martha Gomes
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2017
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5688804/
https://ncbi.nlm.nih.gov/pubmed/29115931
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-017-3726-2
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados